We are live on ! Find out more
Steven Cohen

Steven Cohen Point72 Asset Management

AUM $90B Turnover 35.95%
1-Year Est. Return 47.32%
 

Steven Cohen is the founder of Point72 Asset Management and previously built SAC Capital into one of the industry’s most profitable trading firms. Point72 operates a multi-manager platform combining fundamental long/short equity with systematic and other strategies. Cohen is also a major figure in sports ownership and philanthropy, while remaining one of the most closely followed names in hedge fund trading culture.

This Fund
S&P 500
This Quarter Est. Return
-0.87%
1 Year Est. Return
+47.32%
3 Year Est. Return
+196.68%
5 Year Est. Return
+253.31%
10 Year Est. Return
+901.75%
AUM
$90B
AUM Growth
-$633M
Cap. Flow
-$1.03B
Cap. Flow %
-1.15%
Top 10 Hldgs %
9.57%
Holding
4,740
New
820
Increased
1,398
Reduced
1,421
Closed
884
Avg Time Held Equity + Options
0.8 years
Top 10 Avg Time Held Equity + Options
1.5 years
Top 20 Avg Time Held Equity + Options
1 year
Avg Time Held Equity only
0.6 years
Top 10 Avg Time Held Equity only
0.5 years
Top 20 Avg Time Held Equity only
0.4 years

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$936M
2
CLS icon
Celestica
CLS
+$624M
3
INTC icon
Intel
INTC
+$414M
4
BA icon
Boeing
BA
+$390M
5
T icon
AT&T
T
+$357M

Top Sells

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$677M
2
ASML icon
ASML
ASML
+$524M
3
ORCL icon
Oracle
ORCL
+$445M
4
TSM icon
TSMC
TSM
+$444M
5
SNOW icon
Snowflake
SNOW
+$365M

Sector Composition

Rank Sector Weight
1 Miscellaneous 33.57%
2 Technology 18.01%
3 Industrials 8.74%
4 Consumer Discretionary 8.72%
5 Healthcare 8.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
TDOC icon
3701
CALL
Teladoc Health
TDOC
$1.37B
$41.8K ﹤0.01%
7,200
– –
2025 Q4
3 quarters
SOC icon
3702
CALL
Sable Offshore
SOC
$106M
$41.2K ﹤0.01%
11,900
– –
2026 Q1
2 quarters
LNTH icon
3703
PUT
Lantheus
LNTH
$6.69B
$39.8K ﹤0.01%
400
– –
2026 Q2
1 quarter
USIO icon
3704
Usio
USIO
$55M
$39K ﹤0.01%
+14,485
New +$34.7K
2026 Q3
0 quarters
CLDX icon
3705
CALL
Celldex Therapeutics
CLDX
$2.15B
$38.9K ﹤0.01%
1,200
– –
2026 Q2
1 quarter
IONR icon
3706
Ioneer
IONR
$170M
$38.7K ﹤0.01%
+12,653
New +$42.6K
2026 Q3
0 quarters
IHF icon
3707
CALL
iShares US Healthcare Providers ETF
IHF
$1.42B
$38.4K ﹤0.01%
+700
New +$39.7K
2026 Q3
0 quarters
PLAY icon
3708
PUT
Dave & Buster's
PLAY
$223M
$37K ﹤0.01%
5,800
-15,800
-73% -$148K
2026 Q1
2 quarters
PLX icon
3709
Protalix BioTherapeutics
PLX
$248M
$36K ﹤0.01%
13,027
-12,539
-49% -$31.2K
2026 Q2
1 quarter
RL icon
3710
PUT
Ralph Lauren
RL
$21.6B
$35.5K ﹤0.01%
100
-300
-75% -$111K
2026 Q2
1 quarter
BSIN icon
3711
Big Sky Industrial
BSIN
$47.9M
$35.3K ﹤0.01%
+25,007
New +$34.2K
2026 Q3
0 quarters
HCAT icon
3712
Health Catalyst
HCAT
$99M
$34.5K ﹤0.01%
+19,929
New +$38K
2026 Q3
0 quarters
MARA icon
3713
MARA Holdings
MARA
$2.03B
$34K ﹤0.01%
+3,000
New +$34.5K
2026 Q3
0 quarters
ASPN icon
3714
CALL
Aspen Aerogels
ASPN
$377M
$34K ﹤0.01%
6,200
– –
2026 Q2
1 quarter
LIT icon
3715
Global X Lithium & Battery Tech ETF
LIT
$941M
$33.9K ﹤0.01%
495
– –
2025 Q4
3 quarters
GEO icon
3716
CALL
GEO Group
GEO
$3.93B
$33.5K ﹤0.01%
+1,100
New +$34.1K
2026 Q3
0 quarters
RHI icon
3717
CALL
Robert Half
RHI
$3.85B
$33.1K ﹤0.01%
900
-100
-10% -$3.95K
2025 Q4
3 quarters
XAR icon
3718
State Street SPDR S&P Aerospace & Defense ETF
XAR
$4.57B
$32.6K ﹤0.01%
+141
New +$37.3K
2026 Q3
0 quarters
CLDX icon
3719
PUT
Celldex Therapeutics
CLDX
$2.15B
$32.4K ﹤0.01%
1,000
– –
2026 Q2
1 quarter
ADAG icon
3720
Adagene
ADAG
$119M
$32.2K ﹤0.01%
+10,053
New +$36.7K
2026 Q3
0 quarters
TII icon
3721
Titan Mining
TII
$122M
$32.2K ﹤0.01%
12,563
-2,606
-17% -$6.65K
2026 Q2
1 quarter
PMVP icon
3722
PMV Pharmaceuticals
PMVP
$67.9M
$31.4K ﹤0.01%
+18,819
New +$24.4K
2026 Q3
0 quarters
ROKU icon
3723
PUT
DELISTED
Roku
ROKU
$30.5K ﹤0.01%
200
– –
2026 Q2
1 quarter
MUX icon
3724
PUT
McEwen
MUX
$559M
$30.3K ﹤0.01%
1,700
-23,800
-93% -$447K
2025 Q4
3 quarters
GRWG icon
3725
GrowGeneration
GRWG
$61.5M
$29.8K ﹤0.01%
19,867
+2,729
+16% +$4.26K
2025 Q4
3 quarters

Similar funds

Steven Cohen's Q3 2026 Portfolio in Review

As of Q3 2026, Steven Cohen held 4,740 positions worth $90B, down 0.7% from $90.7B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.

Steven Cohen's Q3 2026 filing shows 820 new, 1,398 increased, 1,421 reduced and 884 closed positions. Its largest new stake was Celestica: 1,886,416 shares worth $682M. The largest sale was Advanced Micro Devices, an estimated $677M.

By sector, the portfolio is most concentrated in Miscellaneous at 34% of assets, up from 32% a quarter earlier, followed by Technology and Industrials.

  • Steven Cohen's largest Q3 2026 buy was Celestica: 1,886,416 shares worth $682M.
  • Steven Cohen added most to Microsoft in Q3 2026, an estimated $936M increase.
  • Steven Cohen's biggest Q3 2026 reduction was Advanced Micro Devices, cutting an estimated $677M.
  • Steven Cohen fully exited Visa in Q3 2026, selling an estimated $297M.
  • Steven Cohen's ten largest holdings make up 9.6% of its $90B portfolio in Q3 2026.
  • Steven Cohen opened 820 new positions and closed 884 in Q3 2026.
  • Steven Cohen's portfolio value fell 0.7% quarter-over-quarter to $90B.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.